Business Description
Adicet Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US0070021086
Share Class Description:
ACET: Ordinary SharesDescription
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.63 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.2 | |||||
| 3-Year EPS without NRI Growth Rate | 17.1 | |||||
| 3-Year FCF Growth Rate | 26.8 | |||||
| 3-Year Book Growth Rate | -11 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.97 | |||||
| 9-Day RSI | 34.28 | |||||
| 14-Day RSI | 37.28 | |||||
| 6-1 Month Momentum % | 67.18 | |||||
| 12-1 Month Momentum % | -64.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.41 | |||||
| Quick Ratio | 8.41 | |||||
| Cash Ratio | 8.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30 | |||||
| Shareholder Yield % | -0.46 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -61.36 | |||||
| ROA % | -52.69 | |||||
| ROIC % | -193.99 | |||||
| ROC (Joel Greenblatt) % | -299.98 | |||||
| ROCE % | -56.68 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.48 | |||||
| Price-to-Tangible-Book | 0.48 | |||||
| EV-to-EBIT | -0.24 | |||||
| EV-to-EBITDA | -0.25 | |||||
| EV-to-Forward-EBITDA | -0.47 | |||||
| EV-to-Forward-Revenue | 13.15 | |||||
| EV-to-FCF | -0.34 | |||||
| Price-to-Net-Current-Asset-Value | 0.65 | |||||
| Price-to-Net-Cash | 0.66 | |||||
| Earnings Yield (Greenblatt) % | -416.67 | |||||
| FCF Yield % | -63.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACET
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adicet Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.31 | ||
| Beta | 1.6 | ||
| Volatility % | 116.3 | ||
| 14-Day RSI | 37.28 | ||
| 14-Day ATR ($) | 0.164126 | ||
| 20-Day SMA ($) | 2.193 | ||
| 12-1 Month Momentum % | -64.16 | ||
| 52-Week Range ($) | 1.1 - 7.5 | ||
| Shares Outstanding (Mil) | 82.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adicet Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adicet Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adicet Bio Inc Frequently Asked Questions
What is Adicet Bio Inc(ACET)'s stock price today?
The current price of ACET is $1.88. The 52 week high of ACET is $7.50 and 52 week low is $1.10.
When is next earnings date of Adicet Bio Inc(ACET)?
The next earnings date of Adicet Bio Inc(ACET) is 2024-05-09 Est..
Does Adicet Bio Inc(ACET) pay dividends? If so, how much?
Adicet Bio Inc(ACET) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers